ICD code T40.422A – Tramadol poisoning by intentional self-harm

Key takeaways

T40.422A is the billable ICD-10-CM code for tramadol poisoning by intentional self-harm, initial encounter

The sixth character carries the intent: 1 is accidental (T40.421A) and 2 is intentional self-harm (T40.422A)

The 7th character ‘A’ marks the first encounter, and submitting T40.422 without one triggers an automatic rejection

Intent already sits inside the poisoning code, so no separate external cause intent code is assigned alongside it

Pabau, practice management software for busy practices, supports ICD-10-CM documentation and electronic claim submission for opioid-related encounters

ICD-10 Code T40.422A: Definition, descriptor, and billable status

ICD-10 Code T40.422A is a fully specified, billable ICD-10-CM code for poisoning by tramadol, intentional self-harm, initial encounter.

It applies when the record documents that the patient took tramadol deliberately to cause self-harm. The encounter must also be the first visit at which the poisoning receives active treatment. The code sits in Chapter 19 of ICD-10-CM (Injury, Poisoning and Certain Other Consequences of External Causes, S00-T88) and is valid in HIPAA-covered transactions. The CDC/NCHS ICD-10-CM web tool confirms it as billable for FY2026.

Code breakdown: Decoding T40.422A character by character

Each character in T40.422A carries a specific meaning within the ICD-10-CM tabular structure. Understanding that logic prevents the two most common submission errors. Coders either truncate the code to T40.422 and drop the 7th character, or they pick an intent character the record does not support.

The intent digit in position 6 is the character coders get wrong most often. Across the T36-T50 poisoning block that character runs in a fixed sequence. It reads 1 for accidental, 2 for intentional self-harm, 3 for assault and 4 for undetermined. Characters 5 and 6 cover adverse effect and underdosing. Where the record does not state the intent, ICD-10-CM Official Guidelines direct the coder to accidental, which means T40.421A rather than T40.422A. Assign T40.422A only where self-harm is documented, and query the provider before inferring it. The chart below maps each documented intent to the code it produces.

Code hierarchy: The T40.4 parent block and the T40.42x sibling family

T40.422A belongs to the T40.42 subcategory, which covers tramadol across every intent and encounter combination. Selecting the wrong sibling is one of the fastest routes to a payer denial. That usually happens when the record supports an accidental exposure but the coder assigns the self-harm character instead.

What T40.422A covers and what it excludes

T40.422A covers deliberate self-poisoning with tramadol hydrochloride (brand name Ultram) and other tramadol formulations classified under ICD-10-CM subcategory T40.42. Tramadol has been a DEA Schedule IV controlled substance since August 2014 under 21 CFR Part 1308. Its ICD-10-CM placement as a synthetic narcotic analgesic reflects that scheduling. Working through the inclusions and exclusions keeps correct-dose adverse effects and underdosing encounters off this code.

• Included: Deliberate tramadol overdose taken to cause self-harm; suicide attempt by tramadol ingestion; self-inflicted tramadol poisoning documented as intentional
• Excluded (use a different code): Accidental tramadol poisoning (T40.421A), tramadol poisoning by assault (T40.423A), and poisoning of undetermined intent (T40.424A)
• Also excluded: Adverse effect of tramadol taken correctly as prescribed (T40.425A), and tramadol underdosing (T40.426A)
• Not captured here: Opioid use disorder – if documented alongside the poisoning, assign the appropriate F11.xx code additionally
• Coded separately when documented: Suicidal ideation (R45.851) and personal history of self-harm (Z91.5) are distinct codes and never substitute for the poisoning code itself

Understanding the 7th character: Initial, subsequent, and sequela

The 7th character on T40.422 determines which phase of care the encounter represents. Getting this wrong does not always trigger an outright denial. It does invite audits and medical necessity disputes when the encounter type conflicts with the services billed.

While the patient is still being actively treated for the poisoning itself, use ‘A’. That covers naloxone administration, monitoring for respiratory depression, and toxicology management. Once the poisoning has been treated and the patient is in follow-up, switch to ‘D’. Sequela encounters are relatively rare and need clear documentation linking the current condition to the original toxic exposure.

Intentional vs accidental poisoning: Choosing the right ICD-10 code

T40.422A applies when the provider documents intentional self-harm. T40.421A applies when the tramadol exposure was accidental. The distinction matters clinically, because a self-harm encounter triggers psychiatric assessment and safety planning. It matters administratively too, since it drives payer adjudication and public health reporting.

Required secondary codes and sequencing rules for T40.422A

T40.422A is rarely the only code on a tramadol self-harm claim. Codes in the T36-T65 range are combination codes that already carry both the substance and the intent. That is why the CMS ICD-10 coding guidelines do not ask for a separate external cause intent code. What payers do expect is the supporting clinical picture around the poisoning. Opioid use disorder codes in the F11.xx range are frequently paired with T40.422A when the provider documents them.

• External cause codes (not required, reported when documented): The intent lives inside T40.422A, so no X71-X83 self-harm code is added. Place of occurrence (Y92.xx) and activity (Y93.xx) are reported on the initial encounter only, and only where the record documents them.
• Manifestation codes (assign when documented): Code respiratory depression (J96.0x), coma (R40.xx), and other toxidrome manifestations additionally. They belong on the claim wherever the clinical record documents them.
• Opioid use disorder (when documented): Assign the appropriate F11.xx code additionally where the provider documents a concurrent diagnosis. ICD-10-CM Official Guidelines Section I.C.5 and AHA Coding Clinic guidance both support this. Do not infer the diagnosis from the overdose alone.
• Behavioral health codes (when documented): Add depressive or adjustment disorder codes where the provider diagnoses them. They often carry the medical necessity for the psychiatric consult that follows a self-harm admission.
• Sequencing order: T40.422A is listed first as the principal diagnosis when the poisoning is the reason for the encounter. Manifestation codes follow, and any external cause codes are sequenced after the condition codes.

Clinical documentation requirements for T40.422A

Robust documentation protects both medical necessity and code assignment. Providers working in emergency department settings should address each of the following elements for a T40.422A claim to be defensible. Incomplete opioid overdose documentation is a frequent root cause of post-payment audits on these encounters.

• Substance identified: Provider must document tramadol (or tramadol hydrochloride / Ultram) by name. Generic “opioid overdose” without substance identification is insufficient for T40.422A.
• Intent stated: The record must show the exposure was intentional self-harm, a suicide attempt, or a deliberate overdose. Without that statement the guidelines default to accidental intent, which is T40.421A, so query the provider before assigning T40.422A.
• Route and dose (when known): Document the route of ingestion, such as oral or IV. Record the estimated dose or the quantity found at the scene, where the EMS run report or the family supplies it.
• Clinical findings: Vital signs, GCS score, toxidrome presentation (miosis, respiratory depression, sedation), and any confirmatory serum or urine toxicology results.
• Treatment administered: Naloxone administration (dose, route, number of doses required) is a key clinical indicator of opioid toxicity severity and supports medical necessity.
• Psychiatric assessment: Record the suicide risk assessment, the safety plan, and any psychiatric consult. On a self-harm encounter this is what supports the behavioral health services billed alongside the poisoning.
• Encounter type: Confirm whether this is the first active treatment encounter (7th character A) or a follow-up visit (7th character D).

Payer requirements and CMS guidelines for tramadol poisoning claims

The Centers for Medicare and Medicaid Services (CMS) follow ICD-10-CM Official Guidelines when adjudicating T40.422A claims. Individual payers may layer additional requirements on top through Local Coverage Determinations (LCDs). For practices submitting electronic claims, routing through a clearinghouse that validates codes before submission catches structural errors before they reach the payer. A clearinghouse edit that rejects T40.422 for a missing 7th character costs the coder minutes. The same error caught by the payer costs a whole denial cycle.

Payers also expect HIPAA-compliant documentation practices on these claims. The provider record has to support both the code selection and the medical necessity of the services rendered. For Medicare claims, automated clearinghouse code edits catch the most common structural errors before adjudication.

Commercial payers and Medicaid plans may require prior authorization for inpatient admissions and behavioral health stays that follow a self-harm poisoning. Always verify current LCD/NCD requirements with the specific payer before assuming coverage. The superbill for these encounters carries all the secondary codes, not just the principal poisoning code.

Common claim denials for T40.422A and how to avoid them

Most T40.422A denials trace back to one of five structural coding errors. Each is preventable with a pre-submission checklist. Denial management workflows for opioid poisoning encounters should address all five categories below.

Coding tramadol poisoning with naloxone administration

When naloxone (Narcan) is administered during a tramadol overdose encounter, the poisoning code T40.422A remains the principal diagnosis. Naloxone administration is the treatment response to the poisoning, not a separately coded condition. The procedure itself may still need to be captured in additional coding, depending on the setting and the payer. The AAPC Codify ICD-10-CM lookup and commercial encoder tools can confirm current procedure code pairings.

For inpatient encounters (ICD-10-PCS settings), naloxone administration is captured as a procedure code. For outpatient and ED encounters, naloxone drug administration may be billed using an appropriate HCPCS J-code, depending on the specific payer and current formulary year.

Because HCPCS J-codes for naloxone can change annually, coders should verify the current applicable code with the payer rather than relying on a prior-year reference. Pairing an expired J-code with T40.422A turns one claim into two separate correction cycles.

T40.422A vs commonly confused codes: A quick reference

The T40.42x family generates coder confusion because the descriptors differ by a single character. One legacy code still turns up in old crosswalks. T40.4X2A was deleted on October 1, 2020, when ICD-10-CM split T40.4 into fentanyl, tramadol and other synthetic narcotic subcategories. Its current replacement is T40.492A. The table below maps each code to the scenario where it applies. Lookup tools such as ICD List and ResDAC’s ICD codes in Medicare files resource are useful secondary references for confirming code specificity.

How Pabau keeps T40.422A claims structurally clean

A truncated poisoning code usually gets caught the same way any other coding error does. The claim goes out, the payer rejects it, and a biller works backwards from the denial weeks later. By then the encounter is closed and the coder has moved on.

Pabau, practice management software for busy practices, moves that check to the point of submission. Its claims management software validates code structure before the claim goes to Claim.MD for transmission. A missing 7th character or an unsupported intent character is flagged while the chart is still open.

Documentation templates for opioid encounters prompt the provider to state the substance, the intent and the treatment given. That is exactly what an auditor asks for later. The result is fewer rejections on the T40.42x family and shorter correction cycles on the ones that still come back.

Streamline opioid encounter billing with Pabau

Pabau’s claims management software supports ICD-10-CM diagnostic code workflows and electronic claim submission via Claim.MD. Its documentation tools help practices get opioid-related encounters paid on the first submission.

Book a demo

Conclusion

Accurate assignment of ICD-10 Code T40.422A rests on three conditions at once. The sixth character must match the documented intent, which here means self-harm rather than an accidental exposure. The 7th character must match the encounter phase.

The clinical record must also name tramadol, state the intent, and describe the treatment given. Miss any one of the three and the claim either rejects outright or faces a post-payment audit. The query to the provider costs far less than the appeal does.

Practices billing opioid-related encounters benefit from claim submission workflows that validate code structure and secondary code completeness before transmission. Book a demo to see how Pabau checks a T40.422A claim for its 7th character and secondary codes before it is transmitted.

Continue your research

Need to understand how clean claims are built? Clean claim requirements in medical billing covers the structural elements every claim needs to pass payer edits on first submission.

Working through opioid encounter denials? Denial codes in medical billing maps common CARC denial reason codes to the root causes and correction steps.

Looking for guidance on insurance eligibility for these encounters? Insurance eligibility verification explains real-time eligibility checks and how to confirm coverage before service.

Frequently asked questions